Literature DB >> 30341016

Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib.

Diego Kauffmann-Guerrero1, Kathrin Kahnert2, Jörg Kumbrink3, Zulfiya Syunyaeva2, Amanda Tufman2, Rudolf M Huber2.   

Abstract

Entities:  

Keywords:  Concomitant driver mutations; Epithelial growth factor receptor; Next generation sequencing; Non small cell lung cancer; TKI combination

Mesh：

Substances：

Year:  2018        PMID： 30341016     DOI： 10.1016/j.cllc.2018.09.009

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  5 in total

1.  Emergence of Concurrent Multiple EGFR Mutations and MET Amplification in a Patient With EGFR-Amplified Advanced Gastric Cancer Treated With Cetuximab.

Authors:  Yoshiaki Nakamura; Akinori Sasaki; Hiroki Yukami; Tomoko Jogo; Akihito Kawazoe; Yasutoshi Kuboki; Hiroya Taniguchi; Riu Yamashita; Takeshi Kuwata; Miho Ozawa; Maho Nakamura; Takayuki Yoshino; Kohei Shitara
Journal:  JCO Precis Oncol       Date:  2020-11-17

2.  Clinical features and therapeutic options in non-small cell lung cancer patients with concomitant mutations of EGFR, ALK, ROS1, KRAS or BRAF.

Authors:  Xibin Zhuang; Chao Zhao; Jiayu Li; Chunxia Su; Xiaoxia Chen; Shengxiang Ren; Xuefei Li; Caicun Zhou
Journal:  Cancer Med       Date:  2019-04-24       Impact factor: 4.452

Review 3.  Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer.

Authors:  Diego Kauffmann-Guerrero; Kathrin Kahnert; Rudolf M Huber
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

4.  Osimertinib rechallenge under steroid protection following osimertinib-induced pneumonitis: three case studies.

Authors:  Christiane Bickert; Kathrin Kahnert; Diego Kauffmann-Guerrero; Jeremias Götschke; Zulfiya Syunyaeva; Jürgen Behr; Amanda Tufman
Journal:  Ther Adv Med Oncol       Date:  2021-06-10       Impact factor: 8.168

5.  Novel Crizotinib-GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems.

Authors:  József Murányi; Attila Varga; Pál Gyulavári; Kinga Pénzes; Csilla E Németh; Miklós Csala; Lilla Pethő; Antal Csámpai; Gábor Halmos; István Peták; István Vályi-Nagy
Journal:  Int J Mol Sci       Date:  2019-11-08       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.